Skip to content

Annexon ANNX Deferred Offering Costs Included In Other Non Current Assets

Deferred Offering Costs Included In Other Non Current Assets at other companies

Enliven Therapeutics logo
Enliven TherapeuticsELVN
$217K
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$200K-33.3%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$100K0.0%
Schering-Plough logo
Schering-PloughSGP
$0
Sonida Senior Living logo
Sonida Senior LivingSNDA
$0
AMB
Ambiq Micro, Inc.AMBQ
-$75K

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+223%
Enterprise value$718.59M+261%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept annx:DeferredOfferingCostsIncludedInOtherNonCurrentAssets.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's deferred offering costs included in other non current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's deferred offering costs included in other non current assets?
Annexon (ANNX) reported deferred offering costs included in other non current assets of $445K in Q1 2026.
What does deferred offering costs included in other non current assets mean?
This represents costs incurred in connection with potential future equity or debt offerings that are capitalized as assets until the offering is completed or abandoned. Once an offering is successful, these costs are typically reclassified as a reduction of the proceeds from the offering. It serves as an indicator of the company's ongoing efforts and expenditures related to capital raising activities.